Ahmed A. Khames

Dr. Ahmed A. Khames

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AHAbdel Haleem Mostafa Hussein
Abdel Haleem Mostafa Hussein
AKAhmed A. Khames
Ahmed A. Khames
AEAbu-Bakr A. El-Adasy
Abu-Bakr A. El-Adasy
AAAhmed A. Atalla
Ahmed A. Atalla
MAMohamed Abdel-Rady
Mohamed Abdel-Rady
Assem BarakatAssem Barakat
Assem Barakat
The elaboration of new small molecules that target phosphodiesterase enzymes (PDEs), especially those of type 5 (PDE5), is an interesting and emerging topic nowadays. A new series of heterocycle-based aminothiazoles were designed and synthesized from the key intermediate, 3-oxo-N-(thiazol-2-yl)butanamide (a PDE5 inhibitor that retains its amidic function), as an essential pharmacophoric moiety. The PDE5 inhibitors prevent the degradation of cyclic guanosine monophosphate, thereby causing severe hypotension as a marked side effect. Hence, an in vivo testing of the target compounds was conducted to verify its relation with arterial blood pressure. Utilizing sildenafil as the reference drug, Compounds 5, 10a, and 11b achieved 100% inhibitions of PDE5 without significantly lowering the mean arterial blood pressures (115.95 ± 2.91, 110.3 ± 2.84, and 78.3 ± 2.57, respectively). The molecular docking study revealed that the tested compounds exhibited docking poses that were similar to that of sildenafil (exploiting the amide functionality that interacted with GLN:817:A). The molecular shape and electrostatic similarity revealed a comparable physically achievable electrostatic potential with the reference drug, sildenafil. Therefore, these concomitant results revealed that the tested compounds exerted sildenafil-like inhibitory effects (although without its known drawbacks) on blood circulation, thus suggesting that the tested compounds might represent a cornerstone of beneficial drug candidates for the safe treatment for erectile dysfunction.

4 April 2021 in Egyptian Journal of Chemistry
Verified
Journal Article
Closed access
AKAhmed A. Khames
Ahmed A. Khames
AEAhmed A. M. El-Shareef
Ahmed A. M. El-Shareef
AHAbdelhaleem M Hussein
Abdelhaleem M Hussein
AEAbubaker Eladasy
Abubaker Eladasy
IOIsmail M Othman
Ismail M Othman
New series of pyrimidine, pyridine and thiophene derivatives were prepared by reaction of appropriate 3-oxobutanamides with urea, thiourea, active methylene compounds, arylidines, salicyaldehyde, chalcones, benzoylisothiocyanate and aminopyrazoles. The antimicrobial activities were also studied and have been found that; Compounds 2a, 3a, 3c and 9 show activity against some bacterial species, whereas, no activity was observed for compounds 3b, 4, 5, 7e, 7f, 10 and 11 against all bacterial species